Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the sixth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the fifth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the fourth of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the third of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the second of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
Chronic pain affects over 50 million people in the US and 1.5 billion world-wide. This is the first of a series of 9 interactive modules on Pain Management; 7 didactic modules and 2 modules of case studies. Using current evidence-based…
CardioVillage provides cardiovascular education in areas of Practicing Cardiovascular Medicine, Echocardiography, New Topics and Trends, and Fundamentals to help learners understand and best treat their patients according to novel technologies, updated guidelines, and state of practice within cardiovascular medicine.
Exogenous oxytocin (Pitocin) may be the most commonly used drug in obstetrics but it is not benign. Its use in clinical practice is riddled with myths, unsubstantiated by science, that perpetuate poor practice habits. Misuse, overuse, and sometimes abuse in…
Medical error is the third leading cause of death in the US and technology failure is to blame 44% of the time. Perinatal clinicians are frequently unaware of the equipment limitations they use routinely. Non-invasive blood pressure machines, pulse oximeters,…
The obstetric malpractice claim of “a delay in treatment of fetal distress” remains the number one factor In over 20% of claims from multiple PIAA resources. The key to avoiding delaying treatment to a fetus in distress is to recognize…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
